Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
Telehealth company Hims & Hers Health (HIMS) witnessed a major dip in its stock recently despite reporting 95% revenue growth ...
A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...
Jacobin on MSN6d
You’ve Already Paid for Overpriced Weight-Loss DrugsUS taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, ...
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
The FDA first announced in October that Lilly's Zepbound and diabetes drug Mounjaro, both known chemically as tirzepatide, ...
Doctor, doctor, give me the news, Hims & Hers Health (HIMS) has got bad case of the stock market blues. The San Francisco ...
State DHS officials say new weight-loss drugs are driving up costs for Pennsylvania’s Medicaid program, likely leading to ...
Doctor, doctor, give me the news, Hims & Hers Health (HIMS) has got bad case of the stock market blues. The San Francisco ...
A review conducted ... reported vision loss after taking semaglutide or tirzepatide, the active ingredients in Ozempic, Wegovy, Mounjaro and Zepbound. Norris at his current weight of 230 pounds ...
There was a degree of social media backlash last week to the first part of The Skinny Jab Revolution (RTÉ One, Monday, March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback